Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy
Alegiani et al., Rheumatology, doi:10.1093/rheumatology/keab348
https://c19hcq.org/alegiani.html